The effect of biologic therapy for immune-mediated inflammatory diseases on clinical outcomes of COVID-19 in the greater Houston area: A retrospective chart review - 19/08/22

Kevin P. Lee, BS ^a, Misha V. Koshelev, MD, PhD ^b,

D3CODE Team^c

Omar Pacha, MD ^{d, ⁎}

^a University of Texas at Houston McGovern Medical School, Houston, Texas 

^b Department of Dermatology, University of Texas Health Science Center at Houston, Houston, Texas 

^c Data-Driven Determinants for COVID-19 Oncology Discovery Effort (D3CODE) Team, University of Texas, MD Anderson Cancer Center, Houston, Texas 

^d Department of Dermatology, MD Anderson Cancer Center, Houston, Texas 

^∗Correspondence to: Omar Pacha, MD, Department of Dermatology, MD Anderson Cancer Center, 1515 Holcombe, Unit 1452, Houston, TX 77030Department of DermatologyMD Anderson Cancer Center1515 Holcombe, Unit 1452HoustonTX77030